TEMOZOLOMIDE/PEGYLATED LIPOSOMAL DOXORUBICIN IN PROGRESSIVE GLIOBLASTOMA MULTIFORME

被引：0
|
作者：
Dresemann, Gregor [1 ]
机构：
[1] Christophorus Kliniken, Duelman, Germany
来源：
NEURO-ONCOLOGY | 2008年 / 10卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：826 / 827
页数：2
相关论文
共 50 条
  • [21] Pegylated liposomal doxorubicin/carboplatin combination in ovarian cancer, progressing on single-agent pegylated liposomal doxorubicin
    Grenader, Tal
    Rosengarten, Ora
    Isacson, Rut
    Plotkin, Yevgeni
    Gabizon, Alberto
    [J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2012, 3 (10): : 137 - 141
  • [22] Synergistic Effects of Temozolomide and Doxorubicin in the Treatment of Glioblastoma Multiforme: Enhancing Efficacy through Combination Therapy
    Dhungel, Laxmi
    Rowsey, Mandy E.
    Harris, Cayla
    Raucher, Drazen
    [J]. MOLECULES, 2024, 29 (04):
  • [23] Clinical pharmacology of liposomal anthracyclines: Focus on pegylated liposomal doxorubicin
    Solomon, Rebecca
    Gabizon, Alberto A.
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2008, 8 (01): : 21 - 32
  • [24] Pegylated liposomal doxorubicin is less cardiotoxic than conventional doxorubicin
    [J]. Reactions Weekly, 1998, 718 (1) : 6 - 6
  • [25] Impact of combination therapy with repeat surgery and temozolomide for recurrent or progressive glioblastoma multiforme: a prospective trial
    Terasaki, Mizuhiko
    Ogo, Etsuyo
    Fukushima, Shintaro
    Sakata, Kiyohiko
    Miyagi, Naohisa
    Abe, Toshi
    Shigemori, Minoru
    [J]. SURGICAL NEUROLOGY, 2007, 68 (03): : 250 - 254
  • [26] Pegylated liposomal doxorubicin in the treatment of mycosis fungoides
    Lybaek, Dorte
    Iversen, Lars
    [J]. ACTA DERMATO-VENEREOLOGICA, 2006, 86 (06) : 545 - 547
  • [27] In vitro and in vivo characterizations of PEGylated liposomal doxorubicin
    Jiang, Wenlei
    Lionberger, Robert
    Yu, Lawrence X.
    [J]. BIOANALYSIS, 2011, 3 (03) : 333 - 344
  • [28] Cutaneous angiosarcoma Radiochemotherapy with liposomal pegylated doxorubicin
    Boenisch, N.
    Langan, E. A.
    Terheyden, P.
    [J]. HAUTARZT, 2019, 70 (09): : 700 - 706
  • [29] Pegylated liposomal doxorubicin in ovarian cancer treatment
    Nowak-Markwitz, Ewa
    [J]. GINEKOLOGIA POLSKA, 2009, 80 (08) : 615 - 619
  • [30] Molecular mechanisms of temozolomide resistance in glioblastoma multiforme
    Johannessen, Tor-Christian Aase
    Bjerkvig, Rolf
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (05) : 635 - 642
12345